Drug Shortage Report for DAPTOMYCIN FOR INJECTION
Report ID | 156658 |
Drug Identification Number | 02490838 |
Brand name | DAPTOMYCIN FOR INJECTION |
Common or Proper name | DAPTOMYCIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DAPTOMYCIN |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 500MG LYVI |
ATC code | J01XX |
ATC description | OTHER ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-03-14 |
Estimated end date | 2022-04-22 |
Actual end date | 2022-04-20 |
Shortage status | Resolved |
Updated date | 2022-04-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2022-04-20 | French | Compare |
v10 | 2022-04-20 | English | Compare |
v9 | 2022-04-12 | French | Compare |
v8 | 2022-04-12 | English | Compare |
v7 | 2022-04-05 | French | Compare |
v6 | 2022-04-05 | English | Compare |
v5 | 2022-03-15 | English | Compare |
v4 | 2022-03-14 | French | Compare |
v3 | 2022-03-14 | English | Compare |
v2 | 2022-03-14 | French | Compare |
v1 | 2022-03-14 | English | Compare |
Showing 1 to 11 of 11